ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.

Zhu, Tong; Awni, Walid M; Hosmane, Balakrishna; Kelly, Maureen T; Sleep, Darryl J; Stolzenbach, James C; Wan, Katty; Chira, Titus O; Pradhan, Rajendra S

Zhu, Tong; Awni, Walid M; Hosmane, Balakrishna; Kelly, Maureen T; Sleep, Darryl J; Stolzenbach, James C; Wan, Katty; Chira, Titus O; Pradhan, Rajendra S.

Affiliation

Zhu T; Abbott, Abbott Park, IL 60064-6104, USA. Tong.Zhu@abbott.com

J Clin Pharmacol ; 49(1): 63-71, 2009 Jan.

Article in En | MEDLINE | ID: mdl-18952910

Subject(s)

Fenofibrate/analogs & derivatives; Fluorobenzenes/pharmacokinetics; Hypolipidemic Agents/pharmacokinetics; Pyrimidines/pharmacokinetics; Sulfonamides/pharmacokinetics; Adult; Cross-Over Studies; Drug Interactions; Female; Fenofibrate/adverse effects; Fenofibrate/blood; Fenofibrate/pharmacokinetics; Fluorobenzenes/adverse effects; Fluorobenzenes/blood; Humans; Hypolipidemic Agents/adverse effects; Hypolipidemic Agents/blood; Male; Middle Aged; Pyrimidines/adverse effects; Pyrimidines/blood; Rosuvastatin Calcium; Sulfonamides/adverse effects; Sulfonamides/blood; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fenofibrate / Pyrimidines / Sulfonamides / Fluorobenzenes / Hypolipidemic Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2009 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google